Literature DB >> 24528922

Drug hypersensitivity syndrome in a patient receiving vismodegib.

Thomas Lam1, Stephen E Wolverton2, Carrie L Davis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24528922     DOI： 10.1016/j.jaad.2013.11.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  The Use of Noninvasive Optical Coherence Tomography to Monitor the Treatment Progress of Vismodegib and Imiquimod 5% Cream in a Transplant Patient with Advanced Basal Cell Carcinoma of the Nose.

Authors:  Orit Markowitz; Michelle Schwartz
Journal:  J Clin Aesthet Dermatol       Date:  2016-08-01

2.  Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.

Authors:  Sandeep C Chaudhary; Xiuwei Tang; Aadithya Arumugam; Changzhao Li; Ritesh K Srivastava; Zhiping Weng; Jianmin Xu; Xiao Zhang; Arianna L Kim; Kristopher McKay; Craig A Elmets; Levy Kopelovich; David R Bickers; Mohammad Athar
Journal:  Oncotarget       Date:  2015-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.